Applying evidence in practice: appropriate use of empagliflozin in patients with type 2 diabetes and established cardiovascular disease in the cardiology clinic.
Topic:
Diabetes and the Heart
Sponsored by Boehringer Ingelheim & Eli Lilly and Company Diabetes Alliance
Event:
ESC Congress 2018
Congress Presentation
5 more presentations in this session
Advancing the standard of care in patients with type 2 diabetes and established cardiovascular disease: how can we improve patient outcomes? .
Speaker: Professor N. Marx (Aachen, DE) Professor D. McGuire (Dallas, US) Doctor J. Udell (Toronto, CA) Professor S. Verma (Toronto, CA) Professor N. Sattar (Glasgow, GB)
Access the full session
About the event
